no it won't. it's not clear what VBIO actually offers, they've previously ran a completely different line of business (also a pump-and-dump i might add), changed their minds all of a sudden, and now claim they find a cure for ... you tell me. larger drug makers generally don't invest in a company with a few bucks in cash, and a completely unproven product. if so, half the OTC would have been bought out by now.
They even say in the web site the therapeutic effects of cannabis are well known with multiple trials already completed.There deal is targeted delivery they even patented the use of other established drugs through there technolgy that there patents have expired.
Market Data 
Markets 
AI
